Tada - I think you have misinterpreted Bear!

 "Since the AGM we have been given guidance that the top line would be delivered in H1. If you are expecting 250 events by Feb 12th after an updated guidance has been given for H1, are you setting yourself up for future frustration? H1 begins in April, lm not expecting top line until then. If it comes sooner, Yahoo."

I believe he was only stating that if the information that RVX gave us was true, Feb.12th is about the last possible date to reach 250 adjudicated MACE events. That is accepting the 200 events at the AGM and using the lower end of the 10 - 15 events per month of 10 that they gave us. That is the only point he was making and that if it isn't achieved by then, there is a flaw in that information. That is just for end of dosing, not end of trial with follow up and other things he has listed to actually end the trial. He has posted on this numerous times so I don't think he has any thought of it ending before Q2 and maybe well into it so that all fits H1 fine. If we don't get 250 MACE in Q1 , we might be looking at Q3 for top line data.